Summary
77.20 -0.18(-0.23%)07/03/2024
Medtronic Plc (MDT)
Medtronic Plc (MDT)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -0.23 | -3.62 | -5.96 | -9.17 | -7.25 | -10.65 | -12.33 | 39,995.05 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 77.20 | |
| Open | 77.32 | |
| High | 77.75 | |
| Low | 77.09 | |
| Volume | 2,380,938 | |
| Change | -0.18 | |
| Change % | -0.23 | |
| Avg Volume (20 Days) | 4,809,851 | |
| Volume/Avg Volume (20 Days) Ratio | 0.50 | |
| 52 Week Range | 68.84 - 91.00 | |
| Price vs 52 Week High | -15.17% | |
| Price vs 52 Week Low | 12.14% | |
| Range | -0.16 | |
| Gap Up/Down | -0.18 | |
Fundamentals | ||
| Market Capitalization (Mln) | 99,299 | |
| EBIDTA | 8,677,000,192 | |
| PE Ratio | 26.2984 | |
| PEG Ratio | 1.5178 | |
| WallStreet Target Price | 94.00 | |
| Book Value | 38.9520 | |
| Earnings Per Share | 3.1500 | |
| EPS Estimate Current Quarter | 1.2600 | |
| EPS Estimate Next Quarter | 0.0000 | |
| EPS Estimate Current Year | 5.2000 | |
| EPS Estimate Next Year | 5.4500 | |
| Diluted EPS (TTM) | 3.1500 | |
| Revenues | ||
| Profit Marging | 0.1300 | |
| Operating Marging (TTM) | 0.1917 | |
| Return on asset (TTM) | 0.0423 | |
| Return on equity (TTM) | 0.0817 | |
| Revenue TTM | 32,320,000,000 | |
| Revenue per share TTM | 24.2980 | |
| Quarterly Revenue Growth (YOY) | 0.0470 | |
| Quarterly Earnings Growth (YOY) | 0.0780 | |
| Gross Profit (TTM) | 21,715,000,000 | |
| Dividends | ||
| Dividend Share | 2.7500 | |
| Dividend Yield | 0.0333 | |
| Valuations | ||
| Trailing PE | 26.2984 | |
| Forward PE | 14.6628 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.0543 | |
| Revenue Enterprise Value | 3.8137 | |
| EBITDA Enterprise Value | 13.8354 | |
| Shares | ||
| Shares Outstanding | 1,327,820,032 | |
| Shares Float | 1,325,498,850 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.01 | |
| Insider (%) | 0.11 | |
| Institutions (%) | 85.31 | |
07/03 15:31 EST - investorplace.com
Blue-Chip Fire Sale: 3 Stocks the Market is Dead Wrong About
If this year's market volatility has you feeling uneasy, you're not alone. The overvaluation of many tech stocks has created a challenging environment, but plenty of affordable, undervalued blue-chip stocks can provide the stability your portfolio needs.
Blue-Chip Fire Sale: 3 Stocks the Market is Dead Wrong About
If this year's market volatility has you feeling uneasy, you're not alone. The overvaluation of many tech stocks has created a challenging environment, but plenty of affordable, undervalued blue-chip stocks can provide the stability your portfolio needs.
07/02 12:50 EST - zacks.com
Medtronic Loses 5% in a Month: What's Next for MDT Investors?
Medtronic's (MDT) stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.
Medtronic Loses 5% in a Month: What's Next for MDT Investors?
Medtronic's (MDT) stock suffers as a result of geopolitical complications and supply issues despite an expanding portfolio and strong strategic executions.
07/01 23:57 EST - seekingalpha.com
Going Beyond Morningstar's 10 Best Value Stocks List
Morningstar published 10 Best Value Stocks to Buy for the Long Term, undervalued blue-chip stocks with low price to fair value. Valuation and future return of each stock analyzed, compared to the S&P 500, Bristol-Myers has the highest potential rate of return. In comparison to Morningstar's 10 Best Value Stocks with 10 Best Dividend Stocks, Bristol-Myers stands out as undervalued with a high potential return.
Going Beyond Morningstar's 10 Best Value Stocks List
Morningstar published 10 Best Value Stocks to Buy for the Long Term, undervalued blue-chip stocks with low price to fair value. Valuation and future return of each stock analyzed, compared to the S&P 500, Bristol-Myers has the highest potential rate of return. In comparison to Morningstar's 10 Best Value Stocks with 10 Best Dividend Stocks, Bristol-Myers stands out as undervalued with a high potential return.
07/01 07:02 EST - seekingalpha.com
My Best Dividend Aristocrats For July 2024
The ProShares S&P 500 Dividend Aristocrats ETF continues its positive run in 2024, posting a gain of 1.45% in May. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 35 months of tracking these strategies, two strategies are outperforming NOBL, while 1 remain relatively close.
My Best Dividend Aristocrats For July 2024
The ProShares S&P 500 Dividend Aristocrats ETF continues its positive run in 2024, posting a gain of 1.45% in May. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 35 months of tracking these strategies, two strategies are outperforming NOBL, while 1 remain relatively close.
07/01 06:37 EST - globenewswire.com
Medtronic Digital Transformation Strategy Report 2024: Accelerators, Incubators, and Other Innovation Programs
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Medtronic Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. The report provides comprehensive information and insights into Medtronic's technology activities, focusing on its digital transformation strategies and innovation programs. It offers an overview of Medtronic's technology initiatives, covering partnerships, product launches, and acquisitions. Each technology initiative is detailed with insights into the technology theme, objectives, and benefits, giving a clear understanding of the strategic intent behind each move.
Medtronic Digital Transformation Strategy Report 2024: Accelerators, Incubators, and Other Innovation Programs
Dublin, July 01, 2024 (GLOBE NEWSWIRE) -- The "Medtronic Plc - Digital Transformation Strategies" company profile has been added to ResearchAndMarkets.com's offering. The report provides comprehensive information and insights into Medtronic's technology activities, focusing on its digital transformation strategies and innovation programs. It offers an overview of Medtronic's technology initiatives, covering partnerships, product launches, and acquisitions. Each technology initiative is detailed with insights into the technology theme, objectives, and benefits, giving a clear understanding of the strategic intent behind each move.
06/30 10:35 EST - seekingalpha.com
If I Had To Retire With 10 Dividend Aristocrats, It Would Be These
If you want a massive dividend snowball: Get the right combination of dividend yield and growth for maximum compounding effect. Dividend Aristocrats may not always be the best choice due to high valuations and low yields. I refine a list of Dividend Aristocrats from 60+ to 10 based on yield and growth rates if I had to pick just 10.
If I Had To Retire With 10 Dividend Aristocrats, It Would Be These
If you want a massive dividend snowball: Get the right combination of dividend yield and growth for maximum compounding effect. Dividend Aristocrats may not always be the best choice due to high valuations and low yields. I refine a list of Dividend Aristocrats from 60+ to 10 based on yield and growth rates if I had to pick just 10.
06/25 10:11 EST - zacks.com
Medtronic (MDT) Shares Positive Data for MiniMed 780G System
Medtronic (MDT) presents more compelling data showcasing the benefits of the MiniMed 780G system.
Medtronic (MDT) Shares Positive Data for MiniMed 780G System
Medtronic (MDT) presents more compelling data showcasing the benefits of the MiniMed 780G system.
06/21 18:30 EST - prnewswire.com
New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes
With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep DUBLIN and ORLANDO, Fla. , June 21, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that showcases the benefits of the MiniMed™ 780G system.
New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes
With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep DUBLIN and ORLANDO, Fla. , June 21, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that showcases the benefits of the MiniMed™ 780G system.
06/20 16:15 EST - prnewswire.com
Sempra Appoints Jennifer M. Kirk to Board of Directors
SAN DIEGO , June 20, 2024 /PRNewswire/ -- Sempra (NYSE: SRE) (BMV: SRE) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20, 2024.
Sempra Appoints Jennifer M. Kirk to Board of Directors
SAN DIEGO , June 20, 2024 /PRNewswire/ -- Sempra (NYSE: SRE) (BMV: SRE) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20, 2024.
06/20 13:35 EST - investorplace.com
Rags to Riches: 3 Robotics Stocks That Could Make Early Investors Rich
The robots aren't coming. They're already here.
Rags to Riches: 3 Robotics Stocks That Could Make Early Investors Rich
The robots aren't coming. They're already here.
06/20 12:06 EST - seekingalpha.com
10 Upcoming Dividend Increases
I highlight ten companies with a history of raising dividends this week. The list will complete not only June, but the first half of 2024. Dividend King National Fuel Gas Company extends its streak with a 4% increase.
10 Upcoming Dividend Increases
I highlight ten companies with a history of raising dividends this week. The list will complete not only June, but the first half of 2024. Dividend King National Fuel Gas Company extends its streak with a 4% increase.
06/20 10:00 EST - zacks.com
3 Generative AI-Based MedTech Stocks to Keep an Eye On
With the growing influence of GenAI in the MedTech sector, innovators like ZBH, GEHC and MDT are poised to thrive.
3 Generative AI-Based MedTech Stocks to Keep an Eye On
With the growing influence of GenAI in the MedTech sector, innovators like ZBH, GEHC and MDT are poised to thrive.
06/20 08:39 EST - investorplace.com
3 Healthcare Stocks to Buy Now: June 2024
Healthcare stocks offer a haven for investors amidst the uncertainty. The Fed elected to hold interest rates at a 23-year high between 5.25% and 5.5% to combat persistent inflation.
3 Healthcare Stocks to Buy Now: June 2024
Healthcare stocks offer a haven for investors amidst the uncertainty. The Fed elected to hold interest rates at a 23-year high between 5.25% and 5.5% to combat persistent inflation.
06/20 06:00 EST - investorplace.com
3 High-Dividend Stocks to Buy and Hold Forever: June 2024 Edition
Building a portfolio today can be both easy and difficult. It's easy because every bit of data you need to make your choices is available 24/7 with a few taps on the screen.
3 High-Dividend Stocks to Buy and Hold Forever: June 2024 Edition
Building a portfolio today can be both easy and difficult. It's easy because every bit of data you need to make your choices is available 24/7 with a few taps on the screen.
06/14 16:30 EST - prnewswire.com
BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC
TROY, Mich. , June 14, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) as its "Stock to Study" and Medtronic PLC (NYSE: MDT) as its "Undervalued Stock" in the September 2024 issue for investors' informational and educational use.
BetterInvesting™ Magazine Update on Amphastar Pharmaceuticals Inc. and Medtronic PLC
TROY, Mich. , June 14, 2024 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) as its "Stock to Study" and Medtronic PLC (NYSE: MDT) as its "Undervalued Stock" in the September 2024 issue for investors' informational and educational use.
06/14 07:30 EST - seekingalpha.com
Medtronic: Now Is The Time To Buy This Deep Value Dividend Aristocrat
When done right, pairing quality and value can be an especially potent investing strategy. Medtronic's revenue edged higher as currency-neutral non-GAAP EPS dipped a bit in the fiscal fourth quarter. Relative to its size, the company's $17 billion in net debt is quite manageable.
Medtronic: Now Is The Time To Buy This Deep Value Dividend Aristocrat
When done right, pairing quality and value can be an especially potent investing strategy. Medtronic's revenue edged higher as currency-neutral non-GAAP EPS dipped a bit in the fiscal fourth quarter. Relative to its size, the company's $17 billion in net debt is quite manageable.
06/14 06:15 EST - fool.com
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Novo Nordisk and Medtronic are longtime leaders in the healthcare industry. Both are proven innovators with attractive prospects in the years ahead.
Got $200? 2 Healthcare Stocks to Buy and Hold Forever.
Novo Nordisk and Medtronic are longtime leaders in the healthcare industry. Both are proven innovators with attractive prospects in the years ahead.
06/14 01:05 EST - seekingalpha.com
Medtronic: Why I Disagree With The Crowd
MDT stock enjoys a bullish rating from analysts and Seeking Alpha writers. But insider transactions are completely dominated by selling - for good reasons in my view. The valuation is not as attractive as on the surface once growth is factored in.
Medtronic: Why I Disagree With The Crowd
MDT stock enjoys a bullish rating from analysts and Seeking Alpha writers. But insider transactions are completely dominated by selling - for good reasons in my view. The valuation is not as attractive as on the surface once growth is factored in.
06/12 09:15 EST - benzinga.com
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
06/11 18:18 EST - seekingalpha.com
Medtronic plc (MDT) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
Medtronic plc (NYSE:MDT ) Goldman Sachs 45th Annual Global Healthcare Conference Call June 11, 2024 10:40 AM ET Company Participants Geoff Martha - Chairman & Chief Executive Officer Conference Call Participants David Roman - Goldman Sachs David Roman Good morning, everybody. I want to welcome everyone here to the 45th Annual Global Healthcare Conference.
Medtronic plc (MDT) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
Medtronic plc (NYSE:MDT ) Goldman Sachs 45th Annual Global Healthcare Conference Call June 11, 2024 10:40 AM ET Company Participants Geoff Martha - Chairman & Chief Executive Officer Conference Call Participants David Roman - Goldman Sachs David Roman Good morning, everybody. I want to welcome everyone here to the 45th Annual Global Healthcare Conference.